HomeInsights52 Week Low Stocks

Bafna Pharmaceuticals Ltd 52 Week Low

Bafna Pharmaceuticals Ltd 52 Week Low

stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

0.4 K

stocks traded

Last Updated time: 05 Nov 13:56 PM

Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

YEARLOW

73.25

Last updated on: Nov 04, 2024

Key Highlights

  • The 52 Week Low of Bafna Pharmaceuticals Ltd is ₹ 73.25 as of 04 Nov 24.

Company Fundamentals for Bafna Pharmaceuticals Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Bafna Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
28 Oct 202477
25 Oct 202480.94
24 Oct 202482
23 Oct 202481
21 Oct 202478.68
18 Oct 202478.11
15 Oct 202476.75
14 Oct 202478.95
10 Oct 202481.02
08 Oct 202479.42

Asset Value vs Market Value of Bafna Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Bafna Pharmaceuticals Ltd News Hub

News

Bafna Pharmaceuticals to discuss results

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 N...

Read more

04 Nov 202418:39

News

Bafna Pharmaceuticals schedules AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

05 Sep 202410:29

News

Bafna Pharmaceuticals to convene AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

04 Sep 202417:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 A...

Read more

10 Aug 202413:56

News

Bafna Pharmaceuticals to hold board meeting

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 M...

Read more

28 May 202413:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 F...

Read more

03 Feb 202414:11

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week Low of Bafna Pharmaceuticals Ltd

Why is it important to track the 52-week low of Bafna Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Bafna Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Bafna Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Bafna Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Bafna Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Bafna Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Bafna Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Bafna Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Bafna Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Bafna Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Bafna Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Bafna Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Bafna Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*